Latest AI and machine learning research in dementia for healthcare professionals.
Dual specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A), a member of the CMGC kinase family, regulates diverse cellular processes and is implicated in Alzheimer's disease, Down syndrome, cancer, and diabetes. However, the clinical translation of DYRK1A inhibitors remains challenging due to limited selectivity arising from the high structural conservation of the ATP-binding pocket wi...
Neurodegenerative diseases such as Alzheimer's disease (AD) and frontotemporal dementia (FTD) exhibit substantial biological and clinical heterogeneity, complicating diagnosis, subtype characterization, and prediction of disease progression. We introduce PatientSpace, a multimodal graph-based latent representation framework designed to model neurodegenerative disease heterogeneity using T1-weighte...
Cerebral amyloid angiopathy (CAA) commonly co-occurs with Alzheimer's disease (AD), yet the molecular changes that accompany vascular [Formula: see te...
PURPOSE: To examine global research trends in delirium prevention through a bibliometric analysis and provide a structured overview of its development...
This study examined how caregiver-reported interoceptive functioning relates to caregiver-reported sensory processing characteristics in typically dev...
Objective.Artificial intelligence methods for denoising low-count FDG PET brain images are usually evaluated using image quality metrics alone, with l...
PURPOSE: As symptoms progress in people with Alzheimer's disease and related dementias (ADRD), caregivers assume increasing responsibility. The object...
Deep learning (DL) has shown considerable promise for EEG-based dementia assessment; however, rigorous cross-family comparisons under leakage-free and...
BACKGROUND: Alzheimer's Disease (AD) is a complex neurodegenerative disorder, with women comprising nearly two-thirds of individuals with AD. However,...
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder marked by progressive cognitive decline, yet its transcriptional regulatory ar...
The dual activating potential of peroxisome proliferator-activated receptors (PPAR) α and γ offers a promising way to address metabolic issues, neuroi...
Hearing loss is a rising health concern. The World Health Organization estimates that over 1.5 billion people worldwide are currently experiencing hea...
Alzheimer's disease (AD) is a common neurodegenerative disorder. Compared to the limited specificity of single-biomarker detection, the combined detec...
Cognitive impairment often follows stroke. Regular physical activity has been shown to be associated with reduced dementia risk, while the association...
Introduction: diabetes mellitus increases the risk of cognitive impairment, but the role of dietary nutrients remains unclear. Objectives: to develop ...
BACKGROUND: Generative artificial intelligence (AI) has the potential to impact health care by transforming workflows and improving outcomes. Patient-...
BACKGROUND: Artificial intelligence (AI)-generated lifestyle recommendations are increasingly used to support health behavior change. However, AI advi...
BACKGROUND: Medical and welfare facilities in the Noto region of Japan were severely affected by the 2024 Noto Peninsula earthquake and subsequent tor...
OBJECTIVE: Since the 1994 "Back to Sleep" campaign, pediatricians have promoted evidence-based infant safe sleep practices to reduce sleep-related inf...
This study proposes physics-guided neural network (PgNN) approaches for estimating perfusion and blood-brain barrier (BBB) water permeability paramete...